Cargando…
Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
BACKGROUND: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106482/ https://www.ncbi.nlm.nih.gov/pubmed/35600330 http://dx.doi.org/10.1016/j.eclinm.2022.101438 |
_version_ | 1784708295301267456 |
---|---|
author | Richard, Dannebaum Phillip, Suwalski Hosseinali, Asgharian Gracie, Du Zhipei Hai, Lin January, Weiner Holtgrewe, Manuel Charlotte, Thibeault Melina, Müller Xiaomin, Wang Zehra, Karadeniz Jacopo, Saccomanno Jan-Moritz, Doehn Ralf-Harto, Hübner Bernd, Hinzmann Anja, Blüher Sandra, Siemann Dilduz, Telman Norbert, Suttorp Martin, Witzenrath Stefan, Hippenstiel Carsten, Skurk Wolfgang, Poller Leif E, Sander Dieter, Beule Florian, Kurth Toumy, Guettouche Ulf, Landmesser Jan, Berka Khai, Luong Rubelt, Florian Bettina, Heidecker |
author_facet | Richard, Dannebaum Phillip, Suwalski Hosseinali, Asgharian Gracie, Du Zhipei Hai, Lin January, Weiner Holtgrewe, Manuel Charlotte, Thibeault Melina, Müller Xiaomin, Wang Zehra, Karadeniz Jacopo, Saccomanno Jan-Moritz, Doehn Ralf-Harto, Hübner Bernd, Hinzmann Anja, Blüher Sandra, Siemann Dilduz, Telman Norbert, Suttorp Martin, Witzenrath Stefan, Hippenstiel Carsten, Skurk Wolfgang, Poller Leif E, Sander Dieter, Beule Florian, Kurth Toumy, Guettouche Ulf, Landmesser Jan, Berka Khai, Luong Rubelt, Florian Bettina, Heidecker |
author_sort | Richard, Dannebaum |
collection | PubMed |
description | BACKGROUND: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics can be characterized by deciphering the adaptive immune response. METHODS: In this cross-sectional study we analyzed 117 peripheral blood immune repertoires from healthy controls and subjects with mild to severe COVID-19 disease to elucidate the interplay between B and T cells. We used an immune repertoire Primer Extension Target Enrichment method (immunoPETE) to sequence simultaneously human leukocyte antigen (HLA) restricted T cell receptor beta chain (TRB) and unrestricted T cell receptor delta chain (TRD) and immunoglobulin heavy chain (IgH) immune receptor repertoires. The distribution was analyzed of TRB, TRD and IgH clones between healthy and COVID-19 infected subjects. Using McFadden's Adjusted R2 variables were examined for a predictive model. The aim of this study is to analyze the influence of the adaptive immune repertoire on the severity of the disease (value on the World Health Organization Clinical Progression Scale) in COVID-19. FINDINGS: Combining clinical metadata with clonotypes of three immune receptor heavy chains (TRB, TRD, and IgH), we found significant associations between COVID-19 disease severity groups and immune receptor sequences of B and T cell compartments. Logistic regression showed an increase in shared IgH clonal types and decrease of TRD in subjects with severe COVID-19. The probability of finding shared clones of TRD clonal types was highest in healthy subjects (controls). Some specific TRB clones seems to be present in severe COVID-19 (Figure S7b). The most informative models (McFadden´s Adjusted R2=0.141) linked disease severity with immune repertoire measures across all three cell types, as well as receptor-specific cell counts, highlighting the importance of multiple lymphocyte classes in disease progression. INTERPRETATION: Adaptive immune receptor peripheral blood repertoire measures are associated with COVID-19 disease severity. FUNDING: The study was funded with grants from the Berlin Institute of Health (BIH). |
format | Online Article Text |
id | pubmed-9106482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-91064822022-05-16 Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 Richard, Dannebaum Phillip, Suwalski Hosseinali, Asgharian Gracie, Du Zhipei Hai, Lin January, Weiner Holtgrewe, Manuel Charlotte, Thibeault Melina, Müller Xiaomin, Wang Zehra, Karadeniz Jacopo, Saccomanno Jan-Moritz, Doehn Ralf-Harto, Hübner Bernd, Hinzmann Anja, Blüher Sandra, Siemann Dilduz, Telman Norbert, Suttorp Martin, Witzenrath Stefan, Hippenstiel Carsten, Skurk Wolfgang, Poller Leif E, Sander Dieter, Beule Florian, Kurth Toumy, Guettouche Ulf, Landmesser Jan, Berka Khai, Luong Rubelt, Florian Bettina, Heidecker eClinicalMedicine Articles BACKGROUND: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics can be characterized by deciphering the adaptive immune response. METHODS: In this cross-sectional study we analyzed 117 peripheral blood immune repertoires from healthy controls and subjects with mild to severe COVID-19 disease to elucidate the interplay between B and T cells. We used an immune repertoire Primer Extension Target Enrichment method (immunoPETE) to sequence simultaneously human leukocyte antigen (HLA) restricted T cell receptor beta chain (TRB) and unrestricted T cell receptor delta chain (TRD) and immunoglobulin heavy chain (IgH) immune receptor repertoires. The distribution was analyzed of TRB, TRD and IgH clones between healthy and COVID-19 infected subjects. Using McFadden's Adjusted R2 variables were examined for a predictive model. The aim of this study is to analyze the influence of the adaptive immune repertoire on the severity of the disease (value on the World Health Organization Clinical Progression Scale) in COVID-19. FINDINGS: Combining clinical metadata with clonotypes of three immune receptor heavy chains (TRB, TRD, and IgH), we found significant associations between COVID-19 disease severity groups and immune receptor sequences of B and T cell compartments. Logistic regression showed an increase in shared IgH clonal types and decrease of TRD in subjects with severe COVID-19. The probability of finding shared clones of TRD clonal types was highest in healthy subjects (controls). Some specific TRB clones seems to be present in severe COVID-19 (Figure S7b). The most informative models (McFadden´s Adjusted R2=0.141) linked disease severity with immune repertoire measures across all three cell types, as well as receptor-specific cell counts, highlighting the importance of multiple lymphocyte classes in disease progression. INTERPRETATION: Adaptive immune receptor peripheral blood repertoire measures are associated with COVID-19 disease severity. FUNDING: The study was funded with grants from the Berlin Institute of Health (BIH). Elsevier 2022-05-14 /pmc/articles/PMC9106482/ /pubmed/35600330 http://dx.doi.org/10.1016/j.eclinm.2022.101438 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Richard, Dannebaum Phillip, Suwalski Hosseinali, Asgharian Gracie, Du Zhipei Hai, Lin January, Weiner Holtgrewe, Manuel Charlotte, Thibeault Melina, Müller Xiaomin, Wang Zehra, Karadeniz Jacopo, Saccomanno Jan-Moritz, Doehn Ralf-Harto, Hübner Bernd, Hinzmann Anja, Blüher Sandra, Siemann Dilduz, Telman Norbert, Suttorp Martin, Witzenrath Stefan, Hippenstiel Carsten, Skurk Wolfgang, Poller Leif E, Sander Dieter, Beule Florian, Kurth Toumy, Guettouche Ulf, Landmesser Jan, Berka Khai, Luong Rubelt, Florian Bettina, Heidecker Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 |
title | Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 |
title_full | Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 |
title_fullStr | Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 |
title_full_unstemmed | Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 |
title_short | Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 |
title_sort | highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to covid-19 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106482/ https://www.ncbi.nlm.nih.gov/pubmed/35600330 http://dx.doi.org/10.1016/j.eclinm.2022.101438 |
work_keys_str_mv | AT richarddannebaum highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT phillipsuwalski highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT hosseinaliasgharian highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT gracieduzhipei highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT hailin highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT januaryweiner highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT holtgrewemanuel highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT charlottethibeault highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT melinamuller highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT xiaominwang highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT zehrakaradeniz highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT jacoposaccomanno highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT janmoritzdoehn highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT ralfhartohubner highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT berndhinzmann highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT anjabluher highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT sandrasiemann highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT dilduztelman highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT norbertsuttorp highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT martinwitzenrath highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT stefanhippenstiel highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT carstenskurk highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT wolfgangpoller highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT leifesander highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT dieterbeule highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT floriankurth highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT toumyguettouche highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT ulflandmesser highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT janberka highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT khailuong highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT rubeltflorian highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 AT bettinaheidecker highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19 |